International Journal of Clinical Research
International Journal of Clinical Research. 2024; 8: (3) ; 10.12208/j.ijcr.20240118 .
总浏览量: 392
岷县中医院 甘肃定西
*通讯作者： 温瑞,单位：岷县中医院 甘肃定西；
目的 探寻肿瘤标志物联合检验对胃癌诊断的效果。方法 选择我院收治的60例疑似胃癌患者，对其进行肿瘤标志物检验，对结果进行分析。结果 肿瘤标志物检验后，胃癌和良性病理患者分别为42例和18例，检出率对比（P＜0.05）；采用病理检测为金标准，胃癌和良性病变肿瘤标志物的诊断准确率和灵敏度（P＞0.05）。结论 肿瘤标志物联合检验可以使胃癌疾病诊断的准确率提升，使疾病得到更好的诊断。
Objective To explore the effect of combined detection of tumor markers in the diagnosis of gastric cancer. Methods 60 patients with suspected gastric cancer in our hospital were selected to detect tumor markers and the results were analyzed. Results After tumor marker examination, 42 cases of gastric cancer and 18 cases of benign pathology were detected, and the detection rate was compared (P < 0.05). Using pathological detection as the gold standard, the diagnostic accuracy and sensitivity of tumor markers for gastric cancer and benign lesions were determined (P > 0.05). Conclusion The combined test of tumor markers can improve the accuracy of the diagnosis of gastric cancer and make the diagnosis of the disease better.
[1] 陈首新,冯博,唐小茹.粪便常规联合血清肿瘤标志物检验在结、直肠癌诊断中的临床价值分析[J].中文科技期刊数据库（引文版）医药卫生,2021(12):0334-0335338.
[2] 林荣军,陈振奋,杨丽萍,陈冬玲,黎杨杨.血清胃蛋白酶原联合肿瘤标志物CEA、CA199、CA125在胃癌诊断中的价值研究[J].中国当代医药,2021,28(35):184-186.
[3] Baretton G, Kreipe HH, Schirmacher P, et al.HER2 test‐ ing in gastric cancer diagnosis: insights on variables influencing HER2-positivity from a large, multicenter, observa‐ tional study in Germany[J]. Virchows Arch, 2019, 474(5): 551-560.
[4] 李金淼.CEA与CA199及CA125等多项肿瘤标志物联合病理检测在胃癌诊断中的效果观察[J].中文科技期刊数据库(文摘版)医药卫生,2023(7):0166-0169.
[5] 胡彦伟,杨柳,郭君兰,胡小倩,王彩铃.外周血单核细胞M1/M2联合肿瘤标志物检测在胃癌诊断中的应用价值研究[J].四川解剖学杂志,2021,29(2):48-49.
[6] 李恭明.肿瘤标志物CA724、CEA、CA242、CA199联合检测在胃癌临床诊断中的价值分析[J].中文科技期刊数据库(全文版)医药卫生,2023(4):0086-0088.
[7] Jeong S, Kim U, Oh M. Detection of Aberrant Glyco‐ sylation of Serum Haptoglobin for Gastric Cancer Diag‐ nosis Using a Middle-Up-Down Glycoproteome Plat‐ form[J]. Pers Med,2021,11(6):575.
[8] 宋玖桐.肿瘤标志物CEA、CA199、CA724及胃癌两项联合检测在胃癌诊断中的价值评价[J].中文科技期刊数据库（引文版）医药卫生,2021(8):0260-0260262.
[9] 李长瑞,尚休新,范灵,陈俊名,崔仕健.探讨肿瘤标志物CA199、CA125及CEA联合检测在胃癌诊断中的应用价值[J].中文科技期刊数据库（全文版）医药卫生,2022 (10):0130-0133.
[10] 张博,刘威震,段浩,刘敏,李升.肿瘤标志物联合检测在肝门胆管癌诊断和治疗中的研究进展[J].中文科技期刊数据库（全文版）医药卫生,2022(10):0250-0252.
[11] 高峻,史学森,卢干,王旭东,任珂.血清胃蛋白酶原、胃泌素-17及肿瘤标记物联合检测在胃癌筛查和诊断中的价值[J].包头医学院学报,2022,38(3):68-72.
[12] 黄慧嫔,李玲,张敏,刘文俊.多种肿瘤标志物联合检测对卵巢癌术后复发的早期诊断效果研究[J].中文科技期刊数据库（全文版）医药卫生,2022(12):0001-0003.
[13] 王月妹,徐海娟,李磊.糖类抗原 724 癌胚抗原及糖类抗原242肿瘤标志联合检验用于胃癌临床诊断的价值[J].中国药物与临床,2021,21(24):4063-4065.